by Dr. Daniel F. Royal, DO, CTP, JD | Apr 5, 2021 | Coronavirus, Traditional Medicine
This past year, Turtle Healing Band Clinic “(THBC”) created a Dendritic Cell Vaccine (“DCV”) Protocol. The DCV is currently a clinical study with the Indigenous Medicine Institutional Review Board. It began last summer. To date, THBC Has been 100% successful in helping its patients/subjects obtain IgG antibodies to SARS-COV-2. Now, for THBC to move into the next phase of its clinical study, a Wave Bioreactor is needed. This Bioreactor can be used to make a product that can be put into an oral capsule and taken as part of an immune therapy protocol. Currently, there is an oral capsule for the cholera vaccine that is approved by the World Health Organization. THBC has found a Bioreactor for a reasonable price, but donations are needed to purchase it so that THBC can move into the next phase of its DCV clinical study. Donations can be made for the purchase of equipment and supplies needed for the development of an oral capsule to either: (1) THBC (an IRC 7871 non-profit foundation); or (2) New Life Benefit Foundation (“NLBF”)(a IRS 501 (c)(3) non-profit foundation). To request a copy of THBC‘s Wave Bioreactor brochure and/or COVID-19 handout, email firstname.lastname@example.org or call (702) 562-1454.
NATURAL THYROID IS BACK
NATURAL THYROID is now back in stock for THB patients and THBC providers who need it. It is available in capsules of 32.5 mg, 65 mg, and 130 mg. It is also less expensive than the previous NatureThroid THB patients had been previously using. For more information, call (702) 562-1454 or email email@example.com.
by Dr. Daniel F. Royal, DO, CTP, JD | Jan 21, 2021 | Coronavirus
The Turtle Healing Band Clinic (“THBC”) has shown over the past six months that a patient’s dendritic cells, harvested from autologous blood, produces IgG antibodies against SARS-CoV-2 without side-effects. THBC takes blood from patient subjects as part of a clinical study for a Dendritic Cell Vaccine (“DCV”) Protocol. Dendritic Cells were then isolated from the blood, exposed to a “spike protein” for SARS-CoV-2, and returned to the subjects via IV infusion. After 4 weeks, all subjects are found to be “positive” for the SARS-CoV-2 IgG Antibody. When lymph nodes are injected, patient subjects are often positive for antibodies within 2 weeks. These results essentially mean that such patients are now considered “recovered” from “COVID-19” and thus, are technically exempt from any vaccination requirements. What’s astonishing is that THBC has been 100% effective in helping its patient subjects achieve immune protection against SARS-CoV-2 using a natural approach without adjuvants.